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1. Introduction
The population requiring hemodialysis (HD) in the United States continues to grow, with
recent studies reporting over 370,000 Americans with end stage renal disease (ESRD) who
are HD-dependent [1]. The creation of functional HD access is often the limiting step in uti‐
lization of renal replacement therapy (RRT). Since the 1960s, the creation of hemodialysis ac‐
cess has become one of the most commonly performed procedures in the United States with
over 500,000 vascular access procedures performed per year [2]. This represents approxi‐
mately 8% of the annual Medicare budget allocated to patients with ESRD [3]. The magni‐
tude of the associated economic and human costs is further exemplified by the fact that up
to 25% of patients with ESRD will die due to inadequate hemodialysis access [5]. This clini‐
cal situation and societal burden makes understanding the basic management steps and op‐
tions for hemodialysis access of key importance to all healthcare professionals involved in
the care of patients who require HD.
2. Timing of referral
There is only limited literature on the optimal timing of patient referral for placement of vas‐
cular access [6]. What has been shown is that patients with ESRD who are referred to a vas‐
cular access practitioner greater than one month before likely initiation of HD had a
significantly lower chance of having a tunneled catheter as their first access option [7]. The
early placement of arteriovenous access is also associated with a lower risk of sepsis and
mortality [8]. At present, the Society for Vascular Surgery makes the following recommen‐
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dations regarding HD access: (a) Patients should be referred to vascular access surgeons for
placement of permanent hemodialysis access when they have advanced renal disease de‐
fined as MDRD of <20 to 25mL/min who have elected to have hemodialysis as their choice of
renal replacement therapy; (b) If upper extremity arteriovenous access is possible it should
be constructed in these patients as soon as possible; (c) If prosthetic access is to be construct‐
ed this should be delayed until just before the need for dialysis [9].
3. Initial evaluation
The initial evaluation of a patient referred for HD access placement begins with an adequate
history and physical examination. This aids in the determination of the most appropriate ac‐
cess option for the patient [10]. The initial questions should include attention to which is the
patient’s dominant extremity and any history of prior upper extremity interventions or
symptoms of arm claudication. The physical examination should document any physical
evidence that the patient has had a prior central venous catheter (CVC) and the upper ex‐
tremity pulse exam as well as an Allen test (Figure 1) should be performed to evaluate the
palmar arch patency. Further, the patient’s chest, breast, shoulders, and upper arms should
be evaluated for the presence of abnormally enlarged collateral veins which may indicate
the presence of central venous occlusion or stenosis (Figure 2).
Figure 1. The Allen’s test is used to assess the patency of both the radial and ulnar arteries. In this test, the physician
compresses both arteries at the level of the wrist with the hand outstretched. The patient is then asked to open and
close the hand into a fist several times with both arteries still compressed. The hand is then relaxed and the radial
artery is released. The entire palm and digits should fill demonstrating good collateral flow. The test is repeated, with
the ulnar artery being released. Again, the entire palm and digits should fill.
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 Figure 2. Superior vena cava (left) and inferior vena cava (middle) occlusion secondary to central venous catheter. The
inferior vena cava underwent stent recanalization to allow future transplantation (right).
3.1. Initial evaluation: Doppler ultrasound and beyond
Two considerations are crucial when looking for an appropriate arterial target in the crea‐
tion of an arterio-venous (A-V) access point. The artery selected must be capable of not only
delivering blood flow at an adequate rate to support dialysis but must also have adequate
flow to maintain the viability of the tissues distal to the A-V anastomosis [11]. The physical
examination alone is often not sufficient to confirm appropriate vessel patency. One
randomized trial demonstrated that the primary A-V fistula failure rate was as high as 25%
when the pre-operative assessment depended on physical examination alone compared to
6% when noninvasive imaging was used [12]. Routine noninvasive testing should include
bilateral upper limb segmental arterial pressures and Doppler ultrasound scanning or pulse
volume recordings. The focus of this testing should be on documenting the following three
characteristics: (a) the patient should have less than a 20 mmHg difference in systolic blood
pressure between the two arms; (b) the palmar arch should be patent; (c) the arterial target
should have a diameter of 2 mm or greater at the proposed anastomosis point [13, 14]. Dop‐
pler Ultrasound can further aid in identifying any stenotic arterial segments in addition to
describing arterial diameter and flow [15, 16]. If any abnormalities are noted on noninvasive
testing then secondary access site(s) should be considered or the patient should be referred
for an angiogram [17]. Angiography is especially useful in patients with known peripheral
vascular disease or in those with suspected proximal arterial occlusive disease.
The selection of an appropriate venous target is of critical importance. If there is avascular
problem that is going to cause technical difficulties in the creation of an arteriovenous fistula
it is more likely to be venous than arterial in nature. Routine vein mapping provides im‐
proved functionality and patency of arteriovenous fistulas as well as primary fistula forma‐
tion [18, 19]. Preoperative vein mapping has further been shown to decrease the rate of
unsuccessful surgical exploration (18). Color flow Doppler ultrasound is considered superi‐
or to other forms of vein evaluation as it avoids the use of nephrotoxic dyes. Further, vein
mapping by ultrasound allows for evaluation of the depth in addition to size of the vessel in
question [20, 21]. When the history or physical evaluation raises the concern for central ve‐
nous stenosis or occlusion then venography is superior to ultrasound duplex imaging [22].
Magnetic resonance venography (MRV) has been reported as an imaging option for perio‐
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perative evaluation of the central venous anatomy but has not been shown to be more clini‐
cally or cost effective than standard venography [23-25].
4. Tunneled catheters
Though the present clinical guidelines attempt to limit tunneled catheters to <10% of total
permanent hemodialysis access, this percentage continues to be higher at most centers [26].
Beyond this, tunneled catheters often are required to serve as a bridging therapy to matura‐
tion of some A-V fistulas and grafts. Consequently, tunneled HD catheters constitute
>250,000 dialysis access procedures in the United States every year [27].
4.1. Basic options
Dialysis catheters may be divided into short- or long-term devices. The distinction between
the two catheter categories has little to do with anatomic considerations and more so with
catheter type and placement technique. Short-term catheters may be placed at bedside using
standard Seldinger technique into the internal jugular, subclavian or femoral vein. These are
usually double lumen, non-cuffed, non-tunneled catheters. To achieve the best dialysis flow
rates the catheter tip, when in the subclavian or jugular vein, should be located in the supe‐
rior vena cava (SVC) just above the cavoatrial junction. If femoral access is chosen, a longer
catheter should be used to ensure that the tip is within the distal inferior vena cava (IVC).
These short-term catheters are intended for the patient who requires acute HD access and
should ideally be used for <3 weeks. The subclavian vein should be avoided to decrease the
rate of central venous stenosis [28]. It should be noted that many of the temporary HD cath‐
eters are somewhat stiff and may cause some degree of trauma to the SVC, contributing to
potential scar formation/stenosis. In the interest of minimizing such vascular trauma, silastic
catheters can also be used in temporary capacity, without creating a subcutaneous tunnel
and or burying the cuff.
Longer term external HD catheters are in general silastic double lumen catheters with felt
cuffs which require tunneled placement under fluoroscopic guidance. These central venous
catheters (CVC) can be inserted into the internal jugular, subclavian, external jugular or fem‐
oral veins and may be used for six months or longer due to their decreased incidence of in‐
fection [29, 30]. The right internal jugular location is preferred due to generally higher
continuous blood flows available for dialysis and lower complication rates [30, 31]. Again, to
decrease the risk of central venous stenosis dialysis catheters should be placed contralateral
to the proposed future site of any A-V fistulas if possible [32]. Central venous stenosis ap‐
pears to occur more often with the subclavian (40-50% cases) than the internal jugular inser‐
tion (up to 10%) in long-term catheters [33, 34]. Reports estimate the average 1-year catheter
patency at approximately 75% [35] with most catheters lost secondary to bacteremia [32].
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4.2. Tunneled dialysis catheter placement in the difficult access patient
When standard catheter access options for HD have been exhausted in the internal jugular
and subclavian positions, alternatives must be sought. The most common reasons for ve‐
nous site “exhaustion” are venous stenosis or occlusion [36-38]. In an effort to reduce femo‐
ral access for placement of long-term catheters given the increased incidence of infection,
and the risk of iliocaval thrombosis interfering with possible future renal transplantation, al‐
ternative upper extremity access points have been studied. Wellons et al, evaluated a novel
method of accessing the SVC through a supraclavicular approach [39]. In their series fluoro‐
scopic guidance was used to direct placement of the dialysis catheter at a point immediately
cephalad to the head of the right clavicle into the SVC. In that study most catheters func‐
tioned from one to seven months.
Due to the development of central venous occlusion or stenosis many patients develop sig‐
nificant central venous collaterals. Techniques have been described whereby a wire and a
snare is passed through these collaterals and attempted to be placed into a vein which can
be visualized with duplex ultrasonography. Once this occurs the vascular practitioner must
snare the wire into the IVC prior to passing the HD catheter using the conventional Selding‐
er technique [40, 41].
An alternative technique to femoral access for placing a cuffed dialysis catheter into the IVC
is through a translumbar approach. Two case series described the use of this method for HD
access [42, 43]. In this approach the patient is placed in the prone or left lateral decubitus
position. A small incision is made approximately three centimeters lateral to the midline
above the right iliac crest at the L3 vertebral level. Under fluoroscopic guidance a wire is in‐
serted into the IVC. Under direct visualization the HD catheter is then passed in such a man‐
ner that the catheter tip is positioned at the junction of the IVC and the right atrium. For this
approach preliminary data suggests that the rate of catheter thrombosis, fibrin sheath forma‐
tion and infection parallel those of more traditional access sites [44-48]. The cumulative pa‐
tency rate for this approach reported was 52% at 6 months and 17% at 12 months [43].
A somewhat more aggressive option for HD access is the transhepatic venous approach.
This approach has been described mainly in case reports or small patient series [49-52]. The
main concern regarding this approach is not its utility as a functional HD access, but rather
the significant associated morbidity and mortality. In particular, the risks of catastrophic
bleeding, biliary tract fistula formation, infection, hepatic dysfunction, and high rates of dis‐
lodgement make this approach too risky for most patients [53]. From a technical standpoint
it requires more skills than standard venous access approaches. A guide needle is placed un‐
der fluoroscopy approximately halfway through the liver in a direction parallel to the right
and middle hepatic veins and directed toward the confluence of the hepatic veins. Once an
acceptable hepatic vein is engaged, a guide wire is advanced toward the right atrium. The
tract is then dilated until the double lumen dialysis catheter can be placed [54, 55]. In one of
the case series, the complication rate was as high as 29% with one death from massive hem‐
orrhage [54]. This approach has a high rate of catheter malfunction requiring frequent re-
positioning [55]. Most authors stress that this approach should be used only as a last resort.
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A hybrid device between an arteriovenous graft and catheter is the HeRO access option
(Figure 3). This device type is specifically designed for patients who central venous stenosis
which would prevent a fistula or graft from providing enough flow to maintain functional
dialysis. The device is tunneled underneath the skin. An outflow synthetic tube is inserted
into the central vein and advanced past the point of stenosis into the right atrium in order to
provide continuous outflow to the system. A secondary PTFE 6mm graft component is then
anastomosed to a peripheral artery.
 
Figure 3. HeRO device with the tip at the cavo-atrial junction.
5. Arteriovenous fistulas
Of all HD access alternatives available the native A-V fistula is at present preferred. The
NKF-K/DOQI guidelines have prompted the “fistula first” campaign to encourage A-V fis‐
tula as the first access option [56]. The native A-V fistula has the lowest infection rate, best
long term primary patency rates and requires the fewest interventions of any type of access
to remain functional [57, 58]. The society for vascular surgery makes the following Grade 1
recommendations regarding the placement of native A-V access: (a) That the access be
placed as far distally in the upper limb to preserve proximal sites for future use; (b) Upper
limb access sites be used first with the non-dominant arm given preference over dominant
arm only when all other access opportunities are equal [9].
5.1. Forearm access
The first considerations for creation of the A-V fistula must focus on which distal vein to
use. Within the forearm there are several readily attainable anatomic options: the cephalic,
basilic, and antecubital veins. When considering the distal inflow options the arterial choices
include the radial, ulnar and brachial arteries. The distal cephalic vein (Figure 4) is the pre‐
ferred venous option due to its location and the minimal surgical dissection involved [59].
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 Figure 4. The anatomy of the patient guides the direct access type. The classic first option for most patients is the
creation of a Brescia-Cimino-Appel Fistula, an autologous radial artery to cephalic vein fistula [4]. If one can readily
appreciate the arterial pulse and vein then a single longitudinal or curvilinear incision over the anterior aspect of the
wrist is used.
If however, the vein and artery are separated by too great a distance then two separate longitu‐
dinal incisions are made and the vein is ligated distally prior to being passed through a subcuta‐
neous tunnel to create the A-V anastomosis. An additional option is the creation of the so called
“snuffbox fistula” whereby an anastomosis is created between the end of the cephalic vein and
the posterior branch of the radial artery located in the anatomic snuffbox. This anastomosis re‐
quires a single longitudinal incision overlying the palpable pulse of the branch of the radial ar‐
tery. After these initial options have either failed or have been deemed impossible due to
anatomic factors, consideration must be given to more proximal sites in the forearm. The radial
artery and cephalic vein may still be a viable A-V paring more proximally but these procedures
in general require transposition of the vein and will be discussed later.
5.2. Upper arm access
Upper arm access options which do not mandate either transposition or translocation proce‐
dures typically use the cephalic or antecubital veins and the brachial artery. In this situation,
a single transverse incision is created and the cephalic or antecubital vein is mobilized prior
to dissecting out the brachial artery. In cases where the vein and artery are anatomically re‐
mote from one another, two separate incisions are created and the vein is tunneled toward
the artery prior to preforming the anastomosis. In comparison to radiocephalic fistulas, the
brachiocephalic A-V fistula (Figure 5) has been shown to mature faster and has higher long
term patency rates [60].
5.3. Transposition procedures
The objective of a transposition fistula is to move the vein to a more superficial position to
ensure that the vein, once mature, is optimally position for safe HD cannulation. As in all
other fistula formation, care must be taken to evaluate underlying anatomy and access op‐
tions for the individual patient. Several options are available, each with unique limitations
and technical considerations.
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Figure 5. Diagram of brachiocephalic A-V access anatomy.
A radial artery to cephalic vein transposition may be required in the obese patient [61]. For
this particular procedure, sufficient wrist inflow must be available with adequate forearm
cephalic vein size which would otherwise be too deep for successful HD cannulation. In this
option, the cephalic vein is identified in the wrist and mobilized to the antecubital fossa. The
radial artery is identified within the distal portion of the incision. The cephalic vein, after
ligation of the distal aspect, is then tunneled superficially and laterally to the radial artery to
perform the anastomosis. If the distal radial artery is not amenable to create the A-V anasto‐
mosis then a similar approach may be used to mobilize the cephalic vein. However in this
case, the brachial artery is identified in the proximal portion of the incision. The cephalic
vein is again tunneled superficially in a forearm loop configuration to the brachial artery in
order to perform the anastomosis after the distal cephalic is ligated.
A forearm fistula may still be planned if the cephalic vein is not acceptable. In this situation
the basilic vein may be used, although its deeper position makes this more technically chal‐
lenging. An access option may still however be planned using the basilic vein and radial ar‐
tery. The basilic vein is identified in the wrist and mobilized to the antecubital fossa. The
radial artery may then be identified through a separate longitudinal incision, after which the
basilic vein is tunneled superficially and laterally to the radial artery to perform the anasto‐
mosis. Again, if the radial artery is not amenable for use in A-V access creation the basilic
vein may be anastomosed to the brachial artery. The basilic vein is mobilized from the wrist
to the antecubital fossa and the brachial artery is identified within the proximal portion of
the incision or through a separate incision if necessary. The basilic vein is then tunneled su‐
perficially in the forearm in a loop configuration after the distal aspect is ligated prior to per‐
forming the A-V anastomosis. In general, the primary patency rates for brachiobasilic
fistulas are higher than for brachiocephalic [62]. However, secondary patency appears to be
equivocal.
If anatomic considerations preclude the use of a forearm fistula or if forearm fistulas have
already failed, then attention is directed toward the upper arm. There are several upper arm
transposition procedures available. Due to technical considerations, the brachiocephalic up‐
per arm transposition is in general preferred to brachial basilic upper arm transposition ac‐
cess options.
In brachiocephalic upper arm transposition, the cephalic vein is identified just proximal or
distal to the skin crease at the elbow and mobilized toward its origin. The brachial artery is
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identified in the distal aspect of the incision. The cephalic vein is then ligated distally. The
superficial aspect of the vein is labeled to ensure that no torsion of the vein occurs during
tunneling. The vein is then tunneled superficially and medially so that it comfortably aligns
with the artery. If vein mapping demonstrates a cephalic vein <4 mm in diameter then this
procedure may be performed in two stages, whereby the distal cephalic vein is anastomosed
to the brachial and then transposed in four to six weeks [63]. The two stage approach is ben‐
eficial as the small caliber cephalic vein is relatively fragile and may be damaged by an at‐
tempted transposition procedure initially. It is felt that it is better to allow arterialization of
the proximal small cephalic vein such that it becomes more robust prior to attempted trans‐
position. A basilic vein to brachial artery approach may be performed similarly, with techni‐
cal limitations again being the anatomy of the basilic vein and the required deeper
dissection. Much as in the brachiocephalic transposition a two-step staged operation may be
warranted [64]. The described functional patency of these two-stage brachial-basilic fistulas
was 76% at one year [64]. Maturation rates for these two staged transposition procedures
range from 47% to >95% [64-66]. Studies that compare brachiobasilic fistulas with upper arm
grafts have generally found improved primary patency, cumulative patency, and less risk of
infection for fistulas, but mixed results for other complications [66, 67].
Once standard upper extremity A-V access options have been exhausted, lower limb access
may be considered. As with other non-standard access options, the literature supporting the
use of distal extremities is still limited. The use of a saphenous vein loop transposition to the
common femoral artery was first described in 1969 [68]. In this option, the saphenous vein is
exposed and mobilized from the saphenofemoral junction to the knee. The vein may be har‐
vested via open or endoscopic approach. Once an adequate length has been mobilized the
distal component is ligated and the vein is tunneled superficially in a loop configuration so
that it reaches comfortably to the proximal superficial femoral artery. Recent case series
demonstrate poor maturation potential of this technique with nearly 30% of the studied pa‐
tients not achieving functional maturity [69]. In those patients who do obtain functional ma‐
turity the time to secondary failure is approximately 16 months [70]. There are significant
limitations with this technique that must be considered. In patients who are morbidly obese
this may not be a viable option if the pannus overlaps the loop graft preventing comfortable
needle cannulation. Further, the great saphenous vein does not dilate after arteriovenous
creation and only veins which are greater than 3mm in diameter should be used.
If the patient’s saphenous vein is not anatomically usable due to size, but a lower extremity
A-V access is still required for the patient, a femoral artery to femoral vein transposition
may be considered. In this approach, the femoral vein is exposed and mobilized down to the
popliteal vein at the knee. The profunda femoral vein is preserved to prevent venous hyper‐
tension and compartment syndrome. The femoral vein is ligated distally at the knee and
transected. The vein is then tunneled superficially through the subcutaneous tissues lateral
to the vein harvest incision so that it comfortably reaches the superficial femoral artery. The
reported primary and secondary patency rates for this technique at 12 months are 73% and
87%, respectively. However, in the largest reported case series for this technique, limb ische‐
mia requiring additional surgery was common occurring in >30% of patients [71, 72]. One of
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the 25 patients studied developed compartment syndrome which ultimately required an
above knee amputation [71]. Further, the reported flow rates for femoral vein transpositions
can be has high as 2000 mL/min [73] which requires considerable caution in the use of this
technique for patients who have or are at risk for congestive heart failure.
5.4. Translocation procedures
Saphenous vein to forearm translocation procedures for development of A-V access are of
mostly historical note. In overview, the saphenous vein is harvested distal to the saphenofe‐
moral junction to above the knee. Once the vein is harvested, attention is turned to the fore‐
arm of choice. The saphenous vein is placed in a straight configuration between the radial
artery and either the antecubital or the cephalic vein. The saphenous vein is then tunneled
superficially between these two vessels and an anastomosis is performed [74]. Studies exam‐
ining this technique are in general older and do not describe outcomes in terms of functional
patency. Due to this fact comparing this technique to outcomes reported in the contempo‐
rary literature is difficult.
An alternative approach uses a translocated superficial femoral vein. It is critical in this ap‐
proach that the patient’s lower extremity arterial circulation is adequate to heal the wounds
from the vein harvest site. In addition to vein mapping, the patient should undergo Duplex ul‐
trasonography with segmental pressures to ensure sufficiency of the arterial system. It must al‐
so be determined that the femoral vein itself is patent and has a diameter >6 millimeters.
In this technique, an incision is made in the groin and extended along the medial border of
the Sartorius muscle. The muscle is retracted laterally in the proximal thigh and medially in
the distal thigh to allow for adequate exposure of the femoral and popliteal vein. The femo‐
ral vein is harvested next to the profunda vein but significant care is taken not to damage
the profunda vein in order to minimize the development of venous hypertension and distal
compartment syndrome. Attention is then turned toward the upper arm of choice. The bra‐
chial artery proximal to the antecubital fossa is isolated. A tunnel is then created between
the brachial artery and axillary vein over the ventral upper arm. The femoral-popliteal vein
is then reversed and tunneled superficially so that it reaches comfortably between the axil‐
lary vein and brachial artery. Huber et al. reported on the outcome of 30 saphenous vein
translocations [75]. In this series, the primary, primary assisted, and secondary patency rates
for the saphenous vein translocation accesses were 79%, 91%, and 100%, respectively, at 12
months; and 67%, 86%, and 100%, respectively, at 18 months. Two patients developed lower
extremity compartment syndrome after the vein harvest, and nearly 30% of patients devel‐
oped upper limb critical ischemia requiring re-intervention.
6. Prosthetic access
If no autogenous access options exist in the upper extremities then consideration of upper
extremity prosthetic access may be considered. The additional risks of infection in prosthetic
grafts are offset by the fact that prosthetic access options meet maturity for hemodialysis
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sooner than autogenous options. As with all forms of hemodialysis access options, care must
be taken to tailor the surgical approach to the patient’s anatomy and specific dialysis needs.
6.1. Forearm
The main prosthetic access options in the forearm, is the brachial artery to antecubital vein
forearm loop access graft. In this technique a transverse incision is made proximally to the
skin fold crease at the elbow. The brachial artery and antecubital vein are isolated. A 6 mm
or tapered 4-7 mm prosthetic graft is then tunneled in the subcutaneous space of the fore‐
arm. This requires a small distal transverse incision to be made so that the graft may be ap‐
propriately aligned. The anastomoses are then created. A straight line prosthetic graft may
also be used between the radial artery distally and the antecubital vein within the antecubi‐
tal fossa. The vein is again exposed through a transverse incision distal to the skin crease of
the elbow and a distal longitudinal incision is made over the pulse of the radial artery. The
prosthetic graft is then tunneled superficially and laterally such that it is readily amenable to
performing the two anastomoses. In general, prosthetic grafts have inferior primary and sec‐
ondary patency rates and higher incidence of complications including infection and throm‐
bosis when compared with autogenous fistula [66, 76-78].
6.2. Upper arm
Upper arm options for prosthetic graft placement are varied. The brachial artery may be
used but if this is difficult owing to scar formation or prior infection, the axillary artery may
be utilized as inflow. In general, the axillary or basilic veins are used with the graft in either
a loop or straight configuration. Grafts in this area may be cannulated for dialysis access
within 2-4 weeks sooner than native fistula formation [62]. Non-maturity failure is relatively
low in patients receiving an upper arm graft with reported incidence of <10-20%.
6.3. Lower extremity access
Lower extremity prosthetic options are reserved for cases where upper extremity access op‐
tions have been exhausted. The main disadvantage of the lower extremity prosthetic graft is
the increased rate of infection compared to upper limb access options [79-84]. The infection
rates vary from a low of 8% to a high of 41%. Further, there is an associated limb loss with
the prosthetic lower extremity graft which is not observed in upper extremity graft [80-84].
The operation itself is relatively simple due to the large size and anatomic locations of the
femoral vein and artery. This anatomic consideration is reflected in the relatively superior
patency rates for lower extremity access grafts compared to upper limb grafts. Studies
which use the standard convention established by the American Association for Vascular
Surgery (AAVS) demonstrated that the secondary patency rates ranged from 41-85% at 1
year and 26-83% at 2 years [79-84]. Due to anatomic considerations, the surgical manage‐
ment of complications associated with this type of HD access are somewhat easier to man‐
age than chest wall grafts and high axillary grafts. Finally, the patient has both hands free
during HD which theoretically may improve their quality of life.
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Lower extremity A-V graft placement is usually performed under general anesthesia. A lon‐
gitudinal incision is made overlying the femoral pulse. The femoral artery and greater sa‐
phenous vein are exposed. The superior femoral artery and greater saphenous vein near the
saphenofemoral junction or femoral vein (depending on anatomy) are isolated. The superfi‐
cial femoral artery is preferred as an inflow option over the common femoral artery due to
the presumed advantage in dealing with complications such as infection and arterial “steal”
phenomenon in this artery. To perform the mid-thigh loop access, an incision is made along
the medial border of the Sartorius muscle. The muscle is then retracted laterally to gain ac‐
cess to the femoral vessels. The artery and vein of choice are then mobilized and controlled.
The graft must be tunneled over the anterolateral aspect of the thigh which helps ensure po‐
sitional access for hemodialysis without the patient having to externally rotate the thigh. In
general, a 6 mm graft is used though some authors describe the use of 8mm synthetic graft.
6.4. Prosthetic cervical and chest wall access
Most patients who are considered for a cervical or chest wall access procedure have already
had prior central venous HD catheters and multiple upper extremity procedures and inter‐
ventions. Therefore, in patients where these unusual approaches are considered it is impera‐
tive that appropriate imaging studies are performed to confirm central venous patency prior
to any surgery. In addition to anatomic considerations, the dominant handedness of the pa‐
tient influences the choice of right or left sided procedures much as it does in the standard
A-V access options.
Prosthetic chest and cervical access reports date back to 1978 though the information regard‐
ing patency rates and complications is mainly limited to case-based evidence [85-88]. Descri‐
bed options for chest and cervical A-V access options include: (a) brachial artery to jugular
vein access; (b) axillary artery to contralateral axillary or jugular vein; (c) axillary artery to
ipislateral axillary vein loop access. The described secondary patency rates for these proce‐
dures range from 37% to 80% at two years [85-88]. Chest and cervical prosthetic access op‐
tions appear to be associated with a significantly lower infection rate than those of the lower
extremity. The described infection rate for these options ranges from 4% to 15% [85-88]. Fur‐
ther, this access option may be beneficial in patients who are morbidly obese in whom the
anatomic limitations of a lower extremity access option include the size of the pannus [85].
One major disadvantage of these access options is the technical difficulty in obtaining proxi‐
mal control of the axillary vessels.
7. Arterial-arterial access procedures
Arterial-arterial access procedures (Figure 6) should only be considered after all convention‐
al options have failed. The literature describing these procedures is relatively scant and re‐
lies mainly on a few case series and reports [89, 90]. Bunger et al. reported a series of 20
patients who had axillary artery to axillary artery interposition with PTFE grafts [89]. These
patients had a 30% re-operative rate. However, at 6 months the grafts had primary and sec‐
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ondary patency rates >90%. Limb ischemia was reported in one patient whose access graft
thrombosed but this resolved after thrombectomy. Zanow et al published a series which
looked at arterial anastomoses involving axillary and femoral arteries [91]. The primary pa‐
tency rates in this series at one year were >70% and >50% at three years. These access proce‐
dures have been suggested for patients who have previous access-related limb ischemia and
high output cardiac failure. There are significant concerns with the arterial-arterial access
options. First, the dialysis units should be aware of the nature of these patients’ access and
should treat each needle cannulation as an arterial stick requiring at least 20 minutes of he‐
mostatic pressure. Second, the flow rates reported in some case series demonstrate that the
arterial-arterial loop access does not appear to provide flow rates as high as standard A-V
access options and therefore dialysis blood flow rates exceeding 400 mL/min may cause dis‐
comfort for the patient. Finally, this access option should not be used to infuse medications
during dialysis as described by the original authors.
 
Figure 6. n example of an arterial-arteial “last resort” hemodialysis access. An arterio-arterial loop graft was placed in
a patient whose venous access options had been exhausted. She later developed graft dysfunction which on angiog‐
raphy proved to be due to neointimal formation at the outflow anastomosis (left image). This responded well to bal‐
loon angioplasty (right-most image).
8. Complications of arteriovenous access
As with all surgical procedures care must be considered in the creation of arteriovenous fis‐
tulas. A wide variety of complications are described in the literature but the following bear
special deliberation.
8.1. Access failure
The mode of failure is usually related to the type of access constructed. Catheter function is
usually limited by the formation of fibrin sheaths at the catheter tip. The life expectancy of
catheters, as previously mentioned, is severely limited by their propensity for infection. For
both native and synthetic arteriovenous accesses the issue is very often the development of
outflow stenosis leading to limited flow dynamics. Such central venous stenoses were classi‐
cally treated with angioplasty or stenting. Of interest, a novel technique has been described
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using radiofrequency (RF) activated wire, and snare technique for recanalization of chronic
central venous occlusions in order to allow passage of HD catheters [92].
Prosthetic grafts have a higher thrombosis rate than native fistula but their functionality is
often more readily returned after intervention. Intimal hyperplasia is the greatest unre‐
solved problem in hemodialysis access. It can occur anywhere in the outflow tract and se‐
verely limits functionality and dialysis flow. It is likely the number one driving factor in
primary patency failure rates after basic anatomic considerations. The literature reports a
wide degree of primary patency rates and as such recognizing this critical problem rather
than exact percentages is of more clear clinical benefit.
Access 1 year primary patency*
Upper Extremity Catheter 43-65%
Femoral Catheter 14%
Translumbar Catheter 17%
Transhepatic Catheter 52%
Forearm extremity AV fistula 60-75%
Upper Extremity AV fistula 64-95%
Upper Extremity AV graft 34-84%
Lower Extremity AV graft 40%
Data based on references [2, 28, 29, 31, 34, 35, 59, 60, 62, 63, 66-68, 70, 75, 77-79, 82, 84, 93-97]
Table 1. Primary 1-year patency rates of different hemodialysis access modalities.
8.2. Steal phenomenon
Ischemic lesions which result from an arterial steal phenomenon directly related to arteriove‐
nous fistula formation (Figure 7) have become more frequent in this increasingly elderly and
high co-morbidity patient population. Clinically significant steal syndrome occurs in 1% of au‐
togenous AV distal access options verses 9% prosthetic AV graft. There are in general two dis‐
tinct types of this steal phenomenon: high flow and low flow. The more readily correctible of
the two is high flow steal. In this situation the fistula with a very low resistance is able to redi‐
rect or ‘steal’ blood from the distal anatomy creating critical ischemia of the digits. In theory,
this should be readily correctable by decreasing the size of the anastomosis and reducing blood
flow through the fistula [98, 99]. Recalling the physics of fluid dynamics and Poiseuille’s law,
one understands that the resistance of a column of fluid is in relation with the fourth power of
the radius. Essentially, this requires that significant reduction in the fistula lumen’s size is
needed to adequately address the flow steal phenomenon. This reduction of course poses the
risk of low flow, thrombosis, and destruction of an otherwise functional fistula. This can be
achieved by banding the fistula’s venous outflow to reduce flow demands on the distal arteri‐
al system or revising the fistula to a more distal artery itself.
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The low flow fistula requires more consideration and is significantly more difficult to ad‐
dress. In general, this results from stenosis of the peripheral arteries such that even normal
blood flow across a fistula will create critical distal ischemia. There are only a few therapeu‐
tic options available. The first is to abandon the fistula via ligation and use a central catheter
as the patient’s only hemodialysis option. An alternative to this is the so called DRIL or dis‐
tal revascularization-interval ligation [100, 101]. In this situation, the artery distal to the arte‐
riovenous fistula anastomosis is ligated such that the fistula no longer feeds off the distal
arterial vessels. The distal artery is then fed via an interposed segment of either vein graft or
synthetic graft.
Figure 7. An example of advanced stage “steal syndrome”.
Stages of Steal Syndrome Grade Clinical Signs
Stage I Mild Pale, blue or cold hand without pain.
Stage II Moderate Pain during exercise or hemodialysis
Stage III Severe Pain at rest
Stage IV Limb Threatening Ulcers, necrosis, gangrene
Table 2. Steal syndrome has been classified into four different stages based on the clinical impact and degree of effect
on the limb in question [93]
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8.3. Congestive heart failure
High fistula flow may cause hyper-circulation and thereby congestive heart failure in the al‐
ready cardiac compromised patient. Hypercirculation occurs when the outflow resistance is
too low. The most common cause of this is an anastomotic lumen which is too large. An ad‐
ditional advantage of the native arteriovenous fistula over synthetic graft is that this en‐
gorged lumen rarely occurs in native tissue [101, 102]. The only way to confirm that the
fistula flow is the direct cause of a patient’s increased congestive heart failure is to perform
quantitative flow studies. Once a diagnosis has been confirmed, banding procedures are rec‐
ommended to decrease the fistula’s lumen size. These procedures have varying rates of suc‐
cess. If necessary the fistula should be ligated to improve the patient’s outcomes after
placement of a central catheter has occurred
8.4. Paget Schroetter syndrome
Paget Schroetter Syndrome or stenosis of the central veins may unfortunately be present in
this patient population prior to vascular access formation. In most patients it is clinically
asymptomatic prior to the demands placed upon the central veins from the arteriovenous
flow dynamics. If a central stenosis is unable to accommodate the flow rates required by the
vascular access point the result will be swelling of the affected limb, cyanosis, and the for‐
mation of significant collaterals. In general, central stenotic regions are the result of prior
subclavian catheters [33, 103]. As with other fistula related complications, onetreatment op‐
tion includes ligation of the anastomosis and the use of another limb after exclusion of bilat‐
eral stenosis. However, given the available endovascular techniques, correction with balloon
angioplasty or stenting should be attempted first with surgical correction of the venous out‐
flow stenosis also a final option [104-106]
8.5. Aneurysm
The formation of aneurysms, in A-V fistulas, is usually the result of progressive destruc‐
tion of the venous vessel wall over time with replacement of normal tissue with inferior
scar  collagenous tissue [107-109].  Once an aneurysm has  developed there  is  a  tendency
for progression due to the wall stress placed on the vessel. Wall tensile stress increases as
the diameter of the vessel increases such that the larger an aneurysmal dilation gets the
greater  the flow dynamic changes which occur within its  boundaries.  Conditions which
favor the formation of an aneurysm and which may be prevented include the repetitive
single site puncture of a fistula for dialysis access. Also any areas of stenosis with their re‐
sultant  pre-stenotic  rise  of  outflow  pressure  and  direct  increase  in  tensile  flow  force
changes will increase the likelihood for aneurysm formation. Aneurysms are cosmetically
unappealing to most patients but beyond this they have the chance for significant compli‐
cations  including  rupture  and  infection.  Therapeutic  treatment  of  aneurysmal  disease
within a fistula includes partial or complete resection and the correction of any accompa‐
nying stenosis [107-109].
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8.6. Pseudoaneurysm
Temporary HD catheters, as previously discussed, are not free of complications. The most
common is of course infection, followed by central stenosis. A further and more localized
complication is the formation of pseudoaneuryms. Pseudoaneuryms occur after arterial
puncture. The puncture site in HD access is in general unplanned, and unintended arterial
punctures do occur. When the arterial puncture site fails to seal, allowing arterial blood to
jet into the surrounding subcutaneous tissue, a pseudoaneurysm may form [110]. These le‐
sions do not have a true wall and their borders are formed by the congealed border of hema‐
toma on subcutaneous tissue. The presentation of a pseudoaneurysm can be varied and may
be as nonspecific as localized discomfort to as ominous as a pulsatile, expanding hematoma.
Doppler ultrasound should be done promptly if the clinical suspicion for pseudoaneurysm
is present. This allows the practitioner to characterize the anatomy of the lesion as well as its
size. In general, observation is the appropriate management choice for smaller pseudoaneur‐
ysms. However, ultrasound-guided thrombin injection or surgery may be required if there
is significant bleeding or the concern for limb ischemia develops. If procedural indications
are not present, the practitioner may place the patient on strict bed rest, remove all optional
anticoagulation, and apply focal compression. If the anatomy of the lesion is favorable then
an ultrasound guided thrombin injection into the aneurysmal neck can immediately resolve
nearly 75% of cases [111, 112].
8.7. AV Fistula/Graft thrombosis
The  most  common  post  procedural  complication  of  arteriovenous  fistula  formation  is
thrombosis. The initiation of dialysis causes flow dynamic changes within the venous out‐
flow. This stimulates intimal hyperplasia mainly at the outflow anastomosis in prosthetic
grafts  and  potentially  anywhere  along  the  utilized  vein  within  the  native  fistula  [93,
113-115]. Defining why the graft or fistula has thrombosed is key to returning it to func‐
tional  flow.  Initially  evaluation  of  the  graft  can  occur  within  the  dialysis  center  itself
when the fistula is accessed. The fistula can be cannulated and the dialysis pump stalled.
The  venous  needle  pressure  is  then  measured.  If  it  is  greater  than  fifty  percent  of  the
mean  arterial  pressure  this  is  indicative  of  outflow malfunction.  More  reliable  is  ultra‐
sound assessment and measurement of flow velocities across the graft. Both of these stud‐
ies indicate graft malfunction and provide a tentative understanding of the abnormalities
at work. Contrast imaging however gives greater anatomic information. Additionally, in‐
vasive  venography  provides  an  opportunity  to  treat  both  venous  and  arterial  stenosis
through the option of balloon angioplasty or more aggressively stent placement [116, 117].
When hybrid diagnostic  and endovascular techniques fail  then open operative interven‐
tion may be required to salvage the graft. Attempted thrombectomy may be done but this
should  also  be  performed in  the  conjunction  with  surgical  revision  of  the  stenotic  seg‐
ment. Surgical revision for fistula/graft stenosis is usually by use of an interposition graft
or patch angioplasty [118].
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9. Summary
Hemodialysis dependent patients require careful evaluation prior to the placement of initial
and subsequent dialysis access sites. Patient factors such as age at presentation, previous
history of central venous access, and long term prognosis must be factored into the consider‐
ation of HD access choice. Distal upper extremity fistulas should be attempted first unless
patient factors preclude them. Only if the feasibility of native fistula options is ruled out
should prosthetic grafts be used in the upper extremity. Central venous catheter HD access
placement should be used sparingly and hopefully as a bridge to the maturation of native
fistula or synthetic upper extremity graft. Lower extremity dialysis options should be re‐
served for only those patients who have exhausted upper extremity choices. Non-standard
A-V or arterial-arterial fistula options should be limited to patients who have no other alter‐
natives and should be performed by surgeons who have had experience in dealing with
these more complicated procedures. Likewise, nonstandard central venous catheter place‐
ment should not be performed unless no other options for HD access are available.
I. Catheters
A. Internal Jugular
B. Subclavian
C. Femoral
D. Translumbar
E. Transhepatic
II. Forearm: Native Tissue
A. Posterior radialcephalic direct access "snuffbox"
B. Radiocephalic anterior acces " Cimino"
C. Radial cephalic forearm transposition
D. Bacial cephalic forearm loop transposition
E. Radial basilic forearm transposition
F. Ulnar Basilic forearm transposition
G. Bacial basilic forearm loop transposition
H. Radial anticubital indirect femoral vein translocation
I. Brachial antiecubital forearm indirect loopoped femoral vein translocation
J. Radial antecubital forearm indirect saphenous vein translocation
K. Brachial antecubital forearm indirect saphenous vein translocation
III. Forearm Prosthetic
A. Radial antecubital forearm straight access
B. Rbracial antecubital forearm looped access
IV. Upper Arm: Native Tissue
A. Brachial cephallic direct
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B. Brachial cephalic upper arm transposition
C. Brachial basilic upper arm transposition
D. Brachial axillary upper arm indirect femoral vein translocation
E. Brachial axillary upper arm indirect saphenous vein translocation
V. Upper Arm Prosthetic
A. Brachial axillary upper arm straight access
B. HeRO hybrid graft
VI. Lower Extremity
A. Femoral vein transposition
B. Prosthetic mid-thigh loop femoral-femoral access
VII. Chest Wall options
A. Axillary artery to axillary vein loop graft
B. Axillary artery to jugular vein straight graft
C. Axillary artery to axillary artery loop graft
Table 3. Summary of currently available hemodialysis access options
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